Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Leukemia

Free Subscription 21.08.2018 1 Acta Haematol 6 Am J Hematol 3 Blood 2 BMC Cancer 3 Bone Marrow Transplant 4 Eur J Haematol 1 Genes Chromosomes Cancer 1 Int J Hematol 1 J Immunol 1 J Pediatr Hematol Oncol 2 Leuk Lymphoma 7 Leuk Res 3 N Engl J Med 1 Oncogene 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Haematol

1. ROZOVSKI U, Keating MJ, Estrov Z
   Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
   Acta Haematol. 2018;140:51-54.
   PubMed     Text format     Abstract available
   
   

   
   Am J Hematol

2. CUNNINGHAM I, Worthley D, Gastroenterologist C
   LEUKEMIA IN GI ORGANS AS CAUSE OF TREATMENT FAILURE: 378 CASES ANALYZED.
   Am J Hematol. 2018 Aug 13. doi: 10.1002/ajh.25250.
   PubMed     Text format     Abstract available
   
   
3. XIA D, Hsi ED, Cin PD, Hasserjian RP, et al
   Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation.
   Am J Hematol. 2018 Aug 13. doi: 10.1002/ajh.25249.
   PubMed     Text format    
   
   
4. ASSI R, Gur HD, Loghavi S, Konoplev SN, et al
   P53 Protein Overexpression in De Novo Acute Myeloid Leukemia Patients with Normal Diploid Karyotype Correlates with FLT3 Internal Tandem Duplication and Worse Relapse-Free Survival.
   Am J Hematol. 2018 Aug 16. doi: 10.1002/ajh.25255.
   PubMed     Text format     Abstract available
   
   
5. MI X, Griffin G, Lee W, Patel S, et al
   Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.
   Am J Hematol. 2018 Aug 16. doi: 10.1002/ajh.25256.
   PubMed     Text format     Abstract available
   
   
6. POPHALI P, Horna P, Lasho TL, Finke CM, et al
   Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of 39 patients.
   Am J Hematol. 2018 Aug 13. doi: 10.1002/ajh.25246.
   PubMed     Text format     Abstract available
   
   
7. HO G, Li Q, Brunson A, Jonas BA, et al
   Complications and Early Mortality in Patients with Acute Promyelocytic Leukemia treated in California.
   Am J Hematol. 2018 Aug 13. doi: 10.1002/ajh.25252.
   PubMed     Text format    
   
   

   
   Blood

8. MEDEIROS BC
   Non-zero-sum game of transfusions: EOL in leukemia.
   Blood. 2018;132:676-678.
   PubMed     Text format    
   
   
9. KIM T, Moon JH, Ahn JS, Kim YK, et al
   Next-generation sequencing based post-transplant monitoring of acute myeloid leukemia.
   Blood. 2018 Aug 14. pii: blood-2018-04-848028. doi: 10.1182/blood-2018-04-848028
   PubMed     Text format     Abstract available
   
   
10. ROGERS KA, Huang Y, Ruppert AS, Awan FT, et al
    Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia.
    Blood. 2018 Aug 15. pii: blood-2018-05-853564. doi: 10.1182/blood-2018-05-853564
    PubMed     Text format     Abstract available
    
    

    
    BMC Cancer

11. BUTRYM A, Lacina P, Kuliczkowski K, Bogunia-Kubik K, et al
    Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia.
    BMC Cancer. 2018;18:107.
    PubMed     Text format     Abstract available
    
    
12. MAHESWARAN R, Morley N
    Incidence, socioeconomic deprivation, volume-outcome and survival in adult patients with acute lymphoblastic leukaemia in England.
    BMC Cancer. 2018;18:25.
    PubMed     Text format     Abstract available
    
    

    
    Bone Marrow Transplant

13. YANADA M, Masuko M, Mori J, Aoki J, et al
    Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0301.
    PubMed     Text format     Abstract available
    
    
14. DABAS R, Dharmani-Khan P, Modi M, Van Slyke T, et al
    Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0296.
    PubMed     Text format     Abstract available
    
    
15. LEE CJ, Savani BN, Mohty M, Gorin NC, et al
    Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Tran
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0286.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Haematol

16. CALITRI C, Ruberto E, Castagnola E
    Antibiotic prophylaxis in neutropenic children with acute leukemia: do the presently available data really support this practice?
    Eur J Haematol. 2018 Aug 14. doi: 10.1111/ejh.13162.
    PubMed     Text format     Abstract available
    
    
17. ULLMARK T, Montano G, Gullberg U
    DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.
    Eur J Haematol. 2018;100:229-240.
    PubMed     Text format     Abstract available
    
    
18. ALJASEM HA, Messner HA, Lipton JH, Kim DDH, et al
    Outcome following second allogeneic hematopoietic cell transplantation: A single-center experience.
    Eur J Haematol. 2018;100:308-314.
    PubMed     Text format     Abstract available
    
    
19. CASADO LF, Hernandez JA, Jarque I, Echave M, et al
    Cost-utility analysis of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukaemia.
    Eur J Haematol. 2018;100:264-272.
    PubMed     Text format     Abstract available
    
    

    
    Genes Chromosomes Cancer

20. ZERKALENKOVA E, Lebedeva S, Kazakova A, Baryshev P, et al
    A case of pediatric acute myeloid leukemia with t(11;16)(q23;q24) leading to a novel KMT2A-USP10 fusion gene.
    Genes Chromosomes Cancer. 2018 Aug 14. doi: 10.1002/gcc.22646.
    PubMed     Text format     Abstract available
    
    

    
    Int J Hematol

21. SATO K, Sakai H, Saiki Y, Uchida A, et al
    Correction to: Cell dynamics during differentiation therapy with all-trans retinoic acid in acute promyelocytic leukemia.
    Int J Hematol. 2018 Aug 12. pii: 10.1007/s12185-018-2515.
    PubMed     Text format     Abstract available
    
    

    
    J Immunol

22. AUE G, Sun C, Liu D, Park JH, et al
    Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.
    J Immunol. 2018 Aug 13. pii: jimmunol.1800570. doi: 10.4049/jimmunol.1800570.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr Hematol Oncol

23. MUNOZ-PEREZ MJ, Casco S, Garza-Gonzalez MDC, Soto-Vega E, et al
    P-glycoprotein Activity Correlates With Treatment Response in 2 Leukemia Child Patients.
    J Pediatr Hematol Oncol. 2018 Aug 17. doi: 10.1097/MPH.0000000000001278.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Lymphoma

24. JABBOUR EJ, Siegartel LR, Lin J, Lingohr-Smith M, et al
    Impact of earlier versus later monitoring on disease progression and healthcare costs among patients with chronic myeloid leukemia in the United States.
    Leuk Lymphoma. 2018 Aug 20:1-7. doi: 10.1080/10428194.2018.1492124.
    PubMed     Text format     Abstract available
    
    
25. NATARAJAN H, Kumar L, Bakhshi S, Sharma A, et al
    Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia.
    Leuk Lymphoma. 2018 Aug 20:1-8. doi: 10.1080/10428194.2018.1485907.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Res

26. DHANGAR S, C SK, S C, Vundinti BR, et al
    Imatinib resistance due to a novel and rare class of mutation at position S348 (1043nt C-->A) of Bcr/Abl gene in a chronic myeloid leukemia patient.
    Leuk Res. 2018;72:96-98.
    PubMed     Text format    
    
    
27. ZEIDNER JF, Foster MC, Blackford AL, Litzow MR, et al
    Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML).
    Leuk Res. 2018;72:92-95.
    PubMed     Text format    
    
    
28. FERRARO F, Gao F, Stockerl-Goldstein K, Westervelt P, et al
    Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data.
    Leuk Res. 2018;72:86-91.
    PubMed     Text format     Abstract available
    
    
29. LEI H, Yang L, Zhou L, Tong Y, et al
    Targeting acute myeloid leukemia CD34(+) stem/progenitor cells with small molecule inhibitor MK-8776.
    Leuk Res. 2018;72:71-73.
    PubMed     Text format    
    
    
30. CHEN X, Wang F, Zhang Y, Wang M, et al
    Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia.
    Leuk Res. 2018;72:99-104.
    PubMed     Text format     Abstract available
    
    
31. NAIR RR, Piktel D, Geldenhuys WJ, Gibson LF, et al
    Combination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemia.
    Leuk Res. 2018;72:59-66.
    PubMed     Text format     Abstract available
    
    
32. GU Y, Han Q, McGrath M, Song C, et al
    Clinical significance of novel SH2B3 mutations in adult Chinese acute lymphoblastic leukemia patients.
    Leuk Res. 2018;72:67-70.
    PubMed     Text format    
    
    

    
    N Engl J Med

33. 
    PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma.
    N Engl J Med. 2018;379:695-697.
    PubMed     Text format    
    
    
34. ISHITSUKA K, Utsunomiya A, Ishida T
    PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma.
    N Engl J Med. 2018;379:695.
    PubMed     Text format    
    
    
35. KATAOKA K, Ogawa S
    PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma.
    N Engl J Med. 2018;379:696.
    PubMed     Text format    
    
    

    
    Oncogene

36. GOROSHCHUK O, Kolosenko I, Vidarsdottir L, Azimi A, et al
    Polo-like kinases and acute leukemia.
    Oncogene. 2018 Aug 13. pii: 10.1038/s41388-018-0443.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

37. KREUGER AL, Middelburg RA, Beckers EAM, de Vooght KMK, et al
    The identification of cases of major hemorrhage during hospitalization in patients with acute leukemia using routinely recorded healthcare data.
    PLoS One. 2018;13:e0200655.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

38. ANCHANG B, Davis KL, Fienberg HG, Williamson BD, et al
    DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity.
    Proc Natl Acad Sci U S A. 2018;115:E4294-E4303.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: